These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7724261)

  • 21. Objective Testing: Urine and Other Drug Tests.
    Hadland SE; Levy S
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):549-65. PubMed ID: 27338974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pediatrician's role in the diagnosis and treatment of substance abuse.
    Alderman EM; Schonberg SK; Cohen MI
    Pediatr Rev; 1992 Aug; 13(8):314-8. PubMed ID: 1437897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Academy of Pediatrics. Committee on Substance Abuse. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention and management of substance abuse.
    American Academy of Pediatrics. Committee on Substance Abuse
    Pediatrics; 1998 Jan; 101(1 Pt 1):125-8. PubMed ID: 11345974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal toxicology screening.
    Hansen RL; Evans AT; Gillogley KM; Hughes CS; Krener PG
    J Perinatol; 1992 Sep; 12(3):220-4. PubMed ID: 1432276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teenagers are right--parents do not know much: an analysis of adolescent-parent agreement on reports of adolescent substance use, abuse, and dependence.
    Fisher SL; Bucholz KK; Reich W; Fox L; Kuperman S; Kramer J; Hesselbrock V; Dick DM; Nurnberger JI; Edenberg HJ; Bierut LJ
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1699-710. PubMed ID: 17010137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive health and blurred professional boundaries.
    Chavkin W; Breitbart V
    Womens Health Issues; 1996; 6(2):89-96. PubMed ID: 8932462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment on "An evaluation of rapid point-of-collection oral fluid drug-testing devices".
    Spiehler V
    J Anal Toxicol; 2004; 28(1):75-6; author reply 76. PubMed ID: 14994718
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection of psychotropic drug abuse].
    Hainaut B; Noirfalise A
    Acta Med Leg Soc (Liege); 1989; 39(1):429-42. PubMed ID: 2520726
    [No Abstract]   [Full Text] [Related]  

  • 29. Underestimation of substance abuse in psychiatric patients by conventional hospital screening.
    Reidy LJ; Junquera P; Van Dijck K; Steele BW; Nemeroff CB
    J Psychiatr Res; 2014 Dec; 59():206-12. PubMed ID: 25262418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug screening: adjunct to the differential diagnosis of drug intoxication.
    Cherkes JK
    Med Health R I; 2006 Nov; 89(11):377-8. PubMed ID: 17168088
    [No Abstract]   [Full Text] [Related]  

  • 31. [Advantages and limitations of Triage DOA screening in clinical and forensic drug testing].
    Moriya F
    Chudoku Kenkyu; 2008 Jul; 21(3):273-83. PubMed ID: 18712071
    [No Abstract]   [Full Text] [Related]  

  • 32. Comprehensive toxicology drug screening data in a pediatric population.
    Garg U; Frazee CC; Scott D; Wasserman G
    J Toxicol Clin Toxicol; 2004; 42(5):681-3. PubMed ID: 15462164
    [No Abstract]   [Full Text] [Related]  

  • 33. Application of the multiple drugs immunoassay test for rapid detection of drug abuse in postmortem urine.
    Srisont S; Chirachariyavej T; Peonim AV
    J Med Assoc Thai; 2010 Nov; 93(11):1301-9. PubMed ID: 21114210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of substance abuse monitoring in a social services context: a primer for child protection workers.
    Moller M; Gareri J; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e177-93. PubMed ID: 20436210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay.
    Wang BT; Colby JM; Wu AH; Lynch KL
    J Anal Toxicol; 2014; 38(9):672-5. PubMed ID: 25248490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass Spectrometry.
    Battal D; Barnes AJ; Castaneto MS; Martin TM; Klette KL; Huestis MA
    Ther Drug Monit; 2015 Dec; 37(6):805-11. PubMed ID: 25992796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Academy of Pediatrics Committee on Substance Abuse: Role of the pediatrician in prevention and management of substance abuse.
    Pediatrics; 1993 May; 91(5):1010-3. PubMed ID: 8474792
    [No Abstract]   [Full Text] [Related]  

  • 38. Adolescent substance use and abuse: recognition and management.
    Griswold KS; Aronoff H; Kernan JB; Kahn LS
    Am Fam Physician; 2008 Feb; 77(3):331-6. PubMed ID: 18297958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current developments in drug testing in oral fluid.
    Pil K; Verstraete A
    Ther Drug Monit; 2008 Apr; 30(2):196-202. PubMed ID: 18367980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical techniques for drug detection in oral fluid.
    Lillsunde P
    Ther Drug Monit; 2008 Apr; 30(2):181-7. PubMed ID: 18367978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.